The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Psychotropic Medication Use Among Medicaid-Enrolled Children With Autism Spectrum Disorders
Open accessAbstract
OBJECTIVE: The objective of this study was to provide national estimates of psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders and to examine child and health system characteristics associated with psychotropic medication use. METHODS: This cross-sectional study used Medicaid claims for calendar year 2001 from all 50 states and Washington, DC, to examine 60,641 children with an autism spectrum disorder diagnosis. Logistic regression with random effects was used to examine the child, county, and state factors associated with psychotropic medication use. RESULTS: Of the sample, 56% used at least 1 psychotropic medication, 20% of whom were prescribed > or = 3 medications concurrently. Use was common even in children aged 0 to 2 years (18%) and 3 to 5 years (32%). Neuroleptic drugs were the most common psychotropic class (31%), followed by antidepressants (25%) and stimulants (22%). In adjusted analyses, male, older, and white children; those who were in foster care or in the Medicaid disability category; those who received additional psychiatric diagnoses; and those who used more autism spectrum disorder services were more likely to have used psychotropic drugs. Children who had a diagnosis of autistic disorder or who lived in counties with a lower percentage of white residents or greater urban density were less likely to use such medications. CONCLUSIONS: Psychotropic medication use is common among even very young children with autism spectrum disorders. Factors unrelated to clinical presentation seem highly associated with prescribing practices. Given the limited evidence base, there is an urgent need to assess the risks, benefits, and costs of medication use and understand the local and national policies that affect medication use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mandell et al. reported that 56% were prescribed at least one psychotropic medication and 20% were prescribed three or more [27].”
From An Update on Psychopharmacological Treatment of Autism Spectrum Disorder (2022) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Fitzmaurice, G. M., Laird, N. M., & Ware, J. H. (2011) · Wiley Series in Probability and Statistics · doi:10.1002/9781119513469 · Cited by 4,639
The American Society of Health System Pharmacists
Beard, E. L. (2001) · JONA s Healthcare Law Ethics and Regulation · doi:10.1097/00128488-200109000-00003 · Cited by 1,685
Risperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574
Epidemiological Surveys of Autism and Other Pervasive Developmental Disorders: An Update
Fombonne, E. (2003) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1025054610557 · Cited by 1,505
Prevalence of Autism in a US Metropolitan Area
Yeargin-Allsopp, M., Rice, C., Karapurkar, T., Doernberg, N., Boyle, C., & Murphy, C. (2003) · JAMA · doi:10.1001/jama.289.1.49 · Cited by 1,248
Factors Associated With Age of Diagnosis Among Children With Autism Spectrum Disorders
Mandell, D. S., Novak, M. M., & Zubritsky, C. D. (2005) · Pediatrics · doi:10.1542/peds.2005-0185 · Cited by 896
Self-citationInternational Classification of Diseases, Ninth Revision
National Cancer Institute (2020) · Definitions · doi:10.32388/bd1nux · Cited by 891
McEvoy, G. K. (1994) · Oncology Issues · doi:10.1080/10463356.1994.11904493 · Cited by 888
Trends in the Prescribing of Psychotropic Medications to Preschoolers
Zito, J. M. (2000) · JAMA · doi:10.1001/jama.283.8.1025 · Cited by 863
(2005) · PubMed · Cited by 775
Race differences in the age at diagnosis among medicaid-eligible children with autism
MANDELL, D. S., LISTERUD, J., LEVY, S. E., & PINTO-MARTIN, J. A. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200212000-00016 · Cited by 684
Self-citationInternet survey of treatments used by parents of children with autism.
Green, V. A., Pituch, K. A., Itchon, J., Choi, A., O’Reilly, M., & Sigafoos, J. (2006) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2004.12.002 · Cited by 617
Autism and pervasive developmental disorders
Volkmar, F. R., Lord, C., Bailey, A., Schultz, R. T., & Klin, A. (2004) · Journal of Child Psychology and Psychiatry · doi:10.1046/j.0021-9630.2003.00317.x · Cited by 616
Psychotropic Practice Patterns for Youth
ZITO, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Magder, L. S., Soeken, K. L., Boles, M., Lynch, F. L., & Riddle, M. A. (2003) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.157.1.17 · Cited by 527
Sleep problems in autism: prevalence, cause, and intervention
Richdale, A. L. (1999) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162299000122 · Cited by 345
James, S. (2004) · Social Service Review · doi:10.1086/424546 · Cited by 292
Bryson, S. E., Rogers, S. J., & Fombonne, E. J. (2003) · The Canadian Journal of Psychiatry · doi:10.1177/070674370304800802 · Cited by 288
Jacobson, J. W., Mulick, J. A., & Green, G. (1998) · Behavioral Interventions · doi:10.1002/(sici)1099-078x(199811)13:4 · Cited by 264
Bussing, R., Schoenberg, N. E., & Perwien, A. R. (1998) · Social Science & Medicine · doi:10.1016/s0277-9536(97)00219-0 · Cited by 258
Mental health services for youths in foster care and disabled youths
dosReis, S., ZITO, J. M., Safer, D. J., & Soeken, K. L. (2001) · American Journal of Public Health · doi:10.2105/ajph.91.7.1094 · Cited by 247
The Economic Impact of Autism in Britain
Järbrink, K., & Knapp, M. R. J. (2001) · Autism · doi:10.1177/1362361301005001002 · Cited by 212
dosReis, S., ZITO, J. M., Safer, D. J., Soeken, K. L., MITCHELL, J. W., & Ellwood, L. C. (2003) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200306000-00004 · Cited by 200
Research Units on Pediatric Psychopharmacology (Rupp) Autism Network
McDougle, C. J., Scahill, L. D., McCracken, J. T., Aman, M. G., Tierney, E., Arnold, L. E., Freeman, B. J., Martin, A., McGough, J. J., Cronin, P., et al. (2000) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30142-1 · Cited by 179
Aman, M. G., Lam, K. S. L., & Collier-Crespin, A. (2003) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1025883612879 · Cited by 165
Concomitant Psychotropic Medication for Youths
Safer, D. J., ZITO, J. M., & dosReis, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.438 · Cited by 162
Validation of the diagnosis of autism in general practitioner records
Fombonne, E. J., Heavey, L., Smeeth, L. L., Rodrigues, L. C., Cook, C., Smith, P. G., Meng, L., & Hall, A. J. (2004) · BMC Public Health · doi:10.1186/1471-2458-4-5 · Cited by 145
Medicaid Expenditures for Children with Autistic Spectrum Disorders: 1994 to 1999
Mandell, D. S., Cao, J., Ittenbach, R. F., & Pinto‐Martin, J. A. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0088-z · Cited by 128
Self-citationHigher-Functioning Pervasive Developmental Disorders: Rates and Patterns of Psychotropic Drug Use
Martin, A., Scahill, L. D., Klin, A., & Volkmar, F. R. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199907000-00024 · Cited by 124
Psychotropic and Anticonvulsant Drugs in Subjects with Autism: Prevalence and Patterns of Use
Aman, M. G., Bourgondien, M. E. V., WOLFORD, P. L., & Sarphare, G. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199512000-00018 · Cited by 124
Langworthy-Lam, K. S., Aman, M. G., & Van Bourgondien, M. E. (2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454602762599853 · Cited by 123
Access and Service Use by Children with Autism Spectrum Disorders in Medicaid Managed Care
Ruble, L. A., Heflinger, C. A., RENFREW, J. W., & Saunders, R. C. (2005) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-004-1026-6 · Cited by 114
Stahmer, A. C., & Mandell, D. S. (2006) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-006-0060-4 · Cited by 104
Self-citationMandell, D. S., Walrath, C., Manteuffel, B. A., Sgro, G., & Pinto‐Martin, J. A. (2005) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-005-3296-z · Cited by 101
Self-citationDifferences Among States in the Identification of Autistic Spectrum Disorders
Mandell, D. S., & Palmer, R. (2005) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.159.3.266 · Cited by 101
Self-citationTsai, L. Y. (1999) · Psychosomatic Medicine · doi:10.1097/00006842-199909000-00008 · Cited by 98
Targeted treatments for symptom domains in child and adolescent autism
Hollander, E., Phillips, A., & Yeh, C.-C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14236-5 · Cited by 93
School District Resources and Identification of Children With Autistic Disorder
Palmer, R. F., Stephen Blanchard, B., Jean, C. R., & Mandell, D. S. (2005) · American Journal of Public Health · doi:10.2105/ajph.2003.023077 · Cited by 85
Self-citationZITO, J. M., Safer, D. J., Zuckerman, I. H., Gardner, J. F., & Soeken, K. L. (2005) · Psychiatric Services · doi:10.1176/appi.ps.56.2.157 · Cited by 83
Pharmacological Interventions in Autism: Theoretical and Practical Issues
Volkmar, F. R. (2001) · Journal of Clinical Child & Adolescent Psychology · doi:10.1207/s15374424jccp3001_9 · Cited by 79
Clinical highlights in bipolar depression: focus on atypical antipsychotics.
Calabrese, J. R., Elhaj, O., Gajwani, P., & Gao, K. (2005) · PubMed · Cited by 76
Multiple Psychotropic Medication Use for Youths: A Two-State Comparison
dosReis, S., ZITO, J. M., Safer, D. J., Gardner, J. F., Puccia, K. B., & Owens, P. L. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.68 · Cited by 72
Wheeler, D. S., Vaux, K. K., Ponaman, M. L., & Poss, B. W. (2003) · Pediatric Emergency Care · doi:10.1097/01.pec.0000101578.65509.71 · Cited by 69
Health care financing for severe developmental disabilities.
Birenbaum, A., Guyot, D., & Cohen, H. J. (1990) · PubMed · Cited by 37
Mandell, D. S., Davis, J. K., Bevans, K. B., & Guevara, J. P. (2008) · Journal of Emotional and Behavioral Disorders · doi:10.1177/1063426607310848 · Cited by 37
Self-citationGreenhill, L. L., Davies, M., Fisher, P. W., FRIED, J., Capasso, L., Skrobala, A. M., Vitiello, B., Riddle, M. A., VARIPATIS, E., Labellarte, M. J., et al. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000046842.56865.ec · Cited by 36
Disability at the dawn of the 21st century : and the state of the states
Braddock, D. L. (2002) · DigitalGeorgetown (Georgetown University Library) · Cited by 26
Self-Advocacy, “Learning Difficulties,” and the Social Model of Disability
Goodley, D., Armstrong, D., Sutherland, K., & Laurie, L. (2003) · Mental Retardation · doi:10.1352/0047-6765(2003)41 · Cited by 24
Safer, D. J., ZITO, J. M., & Gardner, J. F. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.9.1049 · Cited by 21
Research works printed but not linked: 1
- Bonferroni C. The calculation for the protection against groups of tests. In: Studies in Honor of Professor Salvatore Ortu Carboni. [in Italian] Rome, Italy;1935:13–60
Cited by
Sorted by citations
Identification, Evaluation, and Management of Children With Autism Spectrum Disorder
Hyman, S. L., Levy, S. E., Myers, S. M., COUNCIL ON CHILDREN WITH DISABILITIES, S. O. D. A. B. P., Kuo, D. Z., Apkon, S., Davidson, L. F., Ellerbeck, K. A., Foster, J. E. A., Noritz, G. H., et al. (2020) · Pediatrics · doi:10.1542/peds.2019-3447 · Cited by 1,798
Levy, S. E., Mandell, D. S., & Schultz, R. T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61376-3 · Cited by 651
Self-citationKing, B. H., Hollander, E., Sikich, L., McCracken, J. T., Scahill, L., Bregman, J. D., Donnelly, C. L., Anagnostou, E., Dukes, K., Sullivan, L., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.30 · Cited by 482
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
Williams, K., Brignell, A., Randall, M., Silove, N., & Hazell, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004677.pub3 · Cited by 415
Co-occurring psychiatric conditions in autism spectrum disorder
Rosen, T. E., Mazefsky, C. A., Vasa, R. A., & Lerner, M. D. (2018) · International Review of Psychiatry · doi:10.1080/09540261.2018.1450229 · Cited by 325
Metadata
- Authors
- Mandell, D. S., Morales, K. H., Marcus, S. C., Stahmer, A. C., Doshi, J., & Polsky, D. E.
- Affiliations
- Leonard Davis Institute of Health Economics (US)
- University of Pennsylvania (US)
- Rady Children's Hospital-San Diego (US)
- ORCID
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2008-03-01
- Volume
- 121
- Issue
- 3
- Pages
- e441-e448
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- PMC
- PMC2861431
- OpenAlex
- W1980023413
- Cited by
- 295
- References
- 49
- Citations by year
- 2026: 2 · 2025: 17 · 2024: 17 · 2023: 14 · 2022: 20 · 2021: 21 · 2020: 16 · 2019: 16 · 2018: 19 · 2017: 14 · 2016: 19 · 2015: 15 · 2014: 16 · 2013: 35 · 2012: 18
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- University of Pennsylvania
- National Institute of Mental Health (R01MH077000)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Keywords
- psychotropic drug use, autism spectrum disorder, Medicaid, children, antipsychotic drugs, antidepressants, stimulants, prescribing patterns, foster care, county-level factors, racial and ethnic disparities, urban density
- MeSH terms
- Adolescent, Age Factors, Attitude of Health Personnel, Autistic Disorder, Mental Disorders, Child, Child, Preschool, Cross-Sectional Studies, Drug Utilization, Eligibility Determination, Female, Follow-Up Studies, Humans, Male, Medicaid, Practice Patterns, Physicians', Probability, Psychotropic Drugs, Retrospective Studies, Sex Factors, Multicenter Studies as Topic, Incidence, Multivariate Analysis, Treatment Outcome, Risk Assessment, Asperger Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review